GLP-1 medications like Ozempic and Wegovy with the active ingredient semaglutide have reported weight loss in the 15-22 percent range, and even more for some patients
This may include personalized formulations or dosage strengths not available in commercially manufactured medications
Despite these prohibitions, off-label marketing by drug companies is, by some accounts, rampant, and federal regulators routinely obtain headline-grabbing penalties and enforcement sanctions in this arena
In clinical trials of Wegovy, people taking Wegovy were actually less likely to report joint pain than those taking a placebo
This can make people feel full for longer but also could interfere with absorption of other medicines, including birth control pills
You need the greater potency and longer treatment duration of a GLP-1 medication